SC 13-G

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filed

February 1, 2024

Accession Number

0001178913-24-000343

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →